Latest Private Placement News

S2 Resources bolstered its cash reserves with a A$17 million sale of its Fosterville licence to Agnico Eagle and advanced exploration in New South Wales and Western Australia, revealing promising copper mineralisation.

Champion Iron Limited reported robust Q3 FY2026 results with record sales and ongoing progress on its DRPF project, while launching a significant acquisition offer for Rana Gruber.

Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.

Ragusa Minerals has executed a binding agreement to acquire a majority interest in the Purple Pansy manganese-gold project in Arizona, expanding its landholding and raising $600,000 to fund exploration.

Askari Metals has completed a strategic acquisition of the Nejo Gold and Copper Project in Ethiopia and is poised to launch its maiden drilling campaign in early 2026, backed by a strengthened balance sheet and a clear focus on African critical metals.

Radiopharm Theranostics has reported promising interim results from its Phase 2b trial of RAD 101, showing high concordance with MRI in brain metastases patients, while progressing multiple other clinical programs and securing a strong cash position to fund operations into 2027.

Enegex Limited has reported promising gold exploration results in Côte d’Ivoire and Western Australia, supported by a $5 million capital raise and strategic board appointments.

Ragusa Minerals has raised $600,000 through a private placement to fund exploration at its Purple Pansy Manganese-Gold Project in Arizona, supported strongly by existing shareholders.

Sabre Resources has successfully raised $600,000 through a private placement to fast-track exploration of critical minerals in the Northern Territory's Ngalia Basin. The capital injection aims to bolster efforts in uncovering Rare Earths, Uranium, Copper, and Gold at the Dingo Project.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.

NH3 Clean Energy has marked significant progress in its WAH2 clean ammonia project, securing major offtake agreements and government facilitation support alongside a $4 million institutional funding round.